These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4713005)

  • 1. Comparative studies in man and in laboratory animals on 8 - and 9 -trans-tetrahydrocannabinol.
    Karniol IG; Carlini EA
    Pharmacology; 1973; 9(2):115-26. PubMed ID: 4713005
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 3. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa.
    Carlini EA; Santos M; Claussen U; Bieniek D; Korte F
    Psychopharmacologia; 1970 Aug; 18(1):82-93. PubMed ID: 5535578
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of (-) 9 -trans-tetrahydrocannabinol and its selectivity in several models of aggressive behavior.
    Dubinsky B; Robichaud RC; Goldberg ME
    Pharmacology; 1973; 9(4):204-16. PubMed ID: 4736761
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and chronic effects on rats of (-) 1 -trans-tetrahydrocannabinol on unlearned motor tasks.
    Potvin RJ; Fried PA
    Psychopharmacologia; 1972; 26(4):369-78. PubMed ID: 4674065
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men.
    Tashkin DP; Shapiro BJ; Frank IM
    N Engl J Med; 1973 Aug; 289(7):336-41. PubMed ID: 4718513
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetrahydrocannabinols and serum prolactin levels in man.
    Lemberger L; Crabtree R; Rowe H; Clemens J
    Life Sci; 1975 Apr; 16(8):1339-43. PubMed ID: 1094213
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.
    Hollister LE
    Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabis and reverse tolerance: pharmacological entity or psychological phenomenon?
    Fox MN
    Med J Aust; 1973 Nov; 2(18):863-5. PubMed ID: 4205722
    [No Abstract]   [Full Text] [Related]  

  • 13. Shock-elicited fighting and delta-9-tetrahydrocannabinol.
    Manning FJ; Elsmore TF
    Psychopharmacologia; 1972; 25(3):218-28. PubMed ID: 5065158
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of acute and chronic pretreatment with delta1-tetrahydrocannabinol on motor impairment by ethanol in the rat.
    Kalant H; LeBlanc AE
    Can J Physiol Pharmacol; 1974 Apr; 52(2):291-7. PubMed ID: 4838189
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential effects of 9 -THC on locomotor behavior in activity-wheel-habituated and nonhabituated rats.
    Drew WG; Miller LL
    Pharmacology; 1973; 9(1):41-51. PubMed ID: 4708977
    [No Abstract]   [Full Text] [Related]  

  • 17. Labor division of rats under the influence of prolonged administration of (-) 9 -trans-tetrahydrocannabinol.
    Masur J
    Pharmacology; 1973; 9(1):35-40. PubMed ID: 4708976
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance to marijuana-induced tachycardia in man.
    Gibbins RJ; McDougall J; Miles CG; Marshman JA
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):65-76. PubMed ID: 782158
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME
    Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters influencing the effect of delta9-THC on activity wheel behavior.
    Fried PA
    Pharmacol Biochem Behav; 1974 May; 2(3):435-8. PubMed ID: 4837913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.